OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Sam Gandy

2 Projects | 1 Researchers | $586,891 Invested

2016

Icahn School of Medicine at Mount Sinai

Sam Gandy, MD, PhD

Imaging [18F] AV-1451 and [18F] AV-45 in acute and chronic traumatic brain injury - Add On Funding

  • Funding Amount: $187,069
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2014

Icahn School of Medicine at Mount Sinai

Sam Gandy, MD, PhD

Imaging [18F]AV-1451 and [18F]AV-45 in acute and chronic traumatic brain injury

  • Funding Amount: $399,822
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed